共 50 条
High-density lipoprotein mimetics: promises and challenges
被引:27
作者:
Sviridov, Dmitri
[1
]
Remaley, Alan T.
[2
]
机构:
[1] Baker IDI Heart & Diabet Inst, Lab Lipoprot & Atherosclerosis, Melbourne, Vic 3004, Australia
[2] NHLBI, Lipoprot Sect, NIH, Bethesda, MD 20892 USA
基金:
英国医学研究理事会;
关键词:
apolipoproteins;
atherosclerosis;
cholesterolmetabolism;
lipoprotein metabolism;
peptides;
APOLIPOPROTEIN-A-I;
REVERSE CHOLESTEROL TRANSPORT;
PEPTIDE;
4F;
ANTIINFLAMMATORY PROPERTIES;
CORONARY ATHEROSCLEROSIS;
REDUCES ATHEROSCLEROSIS;
AMPHIPATHIC PEPTIDES;
PLASMA-CLEARANCE;
LESION FORMATION;
OXIDIZED LIPIDS;
D O I:
10.1042/BJ20150832
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
The concept of lipoprotein mimetics was developed and extensively tested in the last three decades. Most lipoprotein mimetics were designed to recreate one or several functions of high-density lipoprotein (HDL) in the context of cardiovascular disease; however, the application of this approach is much broader. Lipoprotein mimetics should not just be seen as a set of compounds aimed at replenishing a deficiency or dysfunctionality of individual elements of lipoprotein metabolism but rather as a designer concept with remarkable flexibility and numerous applications in medicine and biology. In the present review, we discuss the fundamental design principles used to create lipoprotein mimetics, mechanisms of their action, medical indications and efficacy in animal models and human studies.
引用
收藏
页码:249 / 259
页数:11
相关论文
共 50 条